Publications


The effects of NMDA receptor antagonists on acute morphine antinociception in mice. E Kozela, P Popik
Amino acids,
PMID:12373532

Wednesday, 9 October 2002
Anxiogenic action of ibogaine. P Popik, M Wróbel
The Alkaloids. Chemistry and biology,
PMID:11705110

Tuesday, 13 November 2001
The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans. A Bisaga, S D Comer, A S Ward, P Popik, H D Kleber, M W Fischman
Psychopharmacology,
PMID:11512037

Monday, 20 August 2001
Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats. E Kozela, W Danysz, P Popik
European journal of pharmacology,
PMID:11438302

Wednesday, 4 July 2001
Cognitive effects of Colostral-Val nonapeptide in aged rats. P Popik, Z Galoch, M Janusz, J Lisowski, J Vetulani
Behavioural brain research,
PMID:11164518

Thursday, 22 February 2001
[Contemporary methods in pharmacotherapy in the opiate dependent treatment]. M Radomska, A Bisaga, P Popik
Przegla̧d lekarski,
PMID:11199877

Tuesday, 30 January 2001
Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders. A Bisaga, P Popik, A Y Bespalov, W Danysz
Expert opinion on investigational drugs,
PMID:11060803

Tuesday, 12 December 2000
Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence. P Popik, M Wróbel, G Nowak
Neuropharmacology,
PMID:10974311

Monday, 13 November 2000
Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice. P Popik, E Kozela, A Pilc
British journal of pharmacology,
PMID:10903986

Wednesday, 13 September 2000